Teikoku Pharma Expands Manufacturing Capabilities to the United States

Teikoku today announced its relocation to San Jose, California. The success of Lidoderm and the growth of US business prompted the move. Located in San Jose’s Innovation Triangle, this new facility, at 75,000 square feet will serve as a center of operation for Teikoku in the United States. Preparations have begun to include hydrogel- and tape-manufacturing lines within this facility. Manufacturing will officially begin on a later announced date.